Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis
NCT01690039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170
Last updated 2018-10-09
Summary
Purpose
1. To compare the performance of the two currently employed urinary acidifications tests in stone formers, the furosemide/fludrocortisone and ammonium chloride loading test.
2. To study the impact of polymorphisms in the genes ATP6V1B1, ATP6V0A4 and SLC4A1 on urinary acidification in stone formers.
Conditions
- Acidosis, Renal Tubular
- Nephrolithiasis
- Vacuolar Proton-Translocating ATPases
Interventions
- DRUG
-
Furosemide-Fludrocortisone-Test (test for urinary acidification)
The presence of a lack of urinary acidification will be assessed by an appropriate test in all patients.
Sponsors & Collaborators
-
Insel Gruppe AG, University Hospital Bern
lead OTHER
Principal Investigators
-
Daniel Fuster, Attending physician Nephrology · Department of Nephrology and Hypertension, Bern University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2016-12-31
- Completion
- 2017-05-12
Countries
- Switzerland
Study Locations
More Related Trials
-
Urinary Biomarkers of the Progression of Alport Kidney Disease
NCT01705132 ·Status: COMPLETED
-
Dose-Dependent Effect of Thiazide in Dent's Disease Hypercalciuria
NCT00638482 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Human Urine Sample Collection for Alport Nephropathy Biomarker Studies
NCT01602835 ·Status: TERMINATED
-
The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.
NCT04393493 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function
NCT01977430 ·Status: UNKNOWN ·Phase: PHASE4
-
Mineralocorticoid Receptor Antagonists in End Stage Renal Disease
NCT01691053 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure
NCT02546583 ·Status: COMPLETED ·Phase: PHASE1
-
Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone
NCT06047912 ·Status: UNKNOWN
-
Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
NCT01100203 ·Status: TERMINATED ·Phase: PHASE3
-
Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease
NCT00638222 ·Status: TERMINATED ·Phase: NA
-
Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
NCT00865501 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Ultra High Dose Diuretics to Treat Heart Failure
NCT06036914 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
NCT07223502 ·Status: RECRUITING ·Phase: PHASE3
-
Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium
NCT02711670 ·Status: COMPLETED ·Phase: NA
-
The Role of Mineralocorticoid Receptors in Vascular Function
NCT00759525 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Identifying Diuretic Resistance in Patients With Acute Heart Failure
NCT02751242 ·Status: COMPLETED
-
Outcome of ADPKD With Octreotide LAR
NCT06193616 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome
NCT00309257 ·Status: COMPLETED ·Phase: PHASE2
-
Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion
NCT00806910 ·Status: WITHDRAWN ·Phase: PHASE4
-
Comparison of Single and Combination Diuretics in Low-Renin Hypertension
NCT02351973 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Diuretics in Kidney Disease
NCT04542304 ·Status: TERMINATED ·Phase: PHASE2
-
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
NCT06190158 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention
NCT06111885 ·Status: RECRUITING ·Phase: PHASE2
-
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
NCT06209359 ·Status: RECRUITING ·Phase: PHASE1
-
Nesiritide and Renal Function After the Total Artificial Heart
NCT01836809 ·Status: TERMINATED ·Phase: PHASE4